2023 Speakers | Kisaco Research

2023 Speakers

Women's Health Innovation Summit 2024
24-25 September, 2024
Boston, MA, USA
  • Author:

    Carolee Lee

    Founder & CEO
    WHAM (Women's Health Access Matters)

    Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.

     

    Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.

    Carolee Lee

    Founder & CEO
    WHAM (Women's Health Access Matters)

    Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.

     

    Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.

  • Author:

    Jen Radin

    Founding Partner
    Deloitte Health Equity Institute

    Jen Radin

    Founding Partner
    Deloitte Health Equity Institute
  • Author:

    Elizabeth Garner

    Chief Scientific Officer
    Ferring Pharmaceuticals U.S.

    Elizabeth Garner, MD, MPH is the US Chief Scientific Officer of Ferring Pharmaceuticals, a leader in reproductive medicine and maternal health, uro-oncology and in specialty areas within orthopedics and gastroenterology including microbiome therapeutics.

     Dr. Garner has nearly 30 years of experience in medicine and industry. Prior to joining Ferring in 2022, she held Chief Medical Officer roles for ObsEva, a women’s health biotechnology company, and Agile Therapeutics, a women’s healthcare company focused on contraception. Earlier, she held leadership roles in medical affairs at Myriad Genetics Laboratories and clinical development at Abbott Laboratories and Merck Research Laboratories. Across her 16-year career in the pharmaceutical industry, she has led or contributed to several US product approvals, including the HPV vaccine-Gardasil®9, Orilissa®-an oral treatment for endometriosis, the novel Twirla® low-dose contraceptive patch, and Rebyota-the first FDA-approved live microbiota product for the prevention of recurrent Clostridium Difficile.

    Dr. Garner is on the Board of Directors of Kezar Life Sciences (KZR), which develops novel therapies for autoimmune diseases and cancer. She is also on the Board of Directors of Sermonix Pharmaceuticals, which focuses on targeted therapies for breast cancer. Dr. Garner is also the current President of the American Medical Women’s Association, the oldest multispecialty organization dedicated to advancing women in medicine and improving women’s health.

    Dr. Garner received joint M.D. and M.P.H. degrees from Harvard Medical (HMS) and Public Health Schools. She trained in obstetrics and gynecology at Brigham and Women’s (BWH)/Massachusetts General Hospitals and completed a fellowship in gynecologic oncology at BWH/Dana Farber Cancer Institute. Prior to transitioning into industry, she was an Assistant Professor at HMS, where she focused on academic clinical practice in gynecologic oncology, basic science ovarian cancer research and teaching and mentorship of residency and fellowship trainees and medical students. Dr. Garner is a frequent panelist and speaker on a range of topics including innovation and investment in women’s health, women’s leadership and diversity, equity, and inclusion (DEI). She is an author of close to 40 peer-reviewed scientific papers. Dr. Garner was also a 2019 awardee of the PharmaVoice 100 Most Inspiring Individuals in the life sciences industry and is the 2022 recipient of the Woman in Science Award from the American Medical Women’s Association.

    Elizabeth Garner

    Chief Scientific Officer
    Ferring Pharmaceuticals U.S.

    Elizabeth Garner, MD, MPH is the US Chief Scientific Officer of Ferring Pharmaceuticals, a leader in reproductive medicine and maternal health, uro-oncology and in specialty areas within orthopedics and gastroenterology including microbiome therapeutics.

     Dr. Garner has nearly 30 years of experience in medicine and industry. Prior to joining Ferring in 2022, she held Chief Medical Officer roles for ObsEva, a women’s health biotechnology company, and Agile Therapeutics, a women’s healthcare company focused on contraception. Earlier, she held leadership roles in medical affairs at Myriad Genetics Laboratories and clinical development at Abbott Laboratories and Merck Research Laboratories. Across her 16-year career in the pharmaceutical industry, she has led or contributed to several US product approvals, including the HPV vaccine-Gardasil®9, Orilissa®-an oral treatment for endometriosis, the novel Twirla® low-dose contraceptive patch, and Rebyota-the first FDA-approved live microbiota product for the prevention of recurrent Clostridium Difficile.

    Dr. Garner is on the Board of Directors of Kezar Life Sciences (KZR), which develops novel therapies for autoimmune diseases and cancer. She is also on the Board of Directors of Sermonix Pharmaceuticals, which focuses on targeted therapies for breast cancer. Dr. Garner is also the current President of the American Medical Women’s Association, the oldest multispecialty organization dedicated to advancing women in medicine and improving women’s health.

    Dr. Garner received joint M.D. and M.P.H. degrees from Harvard Medical (HMS) and Public Health Schools. She trained in obstetrics and gynecology at Brigham and Women’s (BWH)/Massachusetts General Hospitals and completed a fellowship in gynecologic oncology at BWH/Dana Farber Cancer Institute. Prior to transitioning into industry, she was an Assistant Professor at HMS, where she focused on academic clinical practice in gynecologic oncology, basic science ovarian cancer research and teaching and mentorship of residency and fellowship trainees and medical students. Dr. Garner is a frequent panelist and speaker on a range of topics including innovation and investment in women’s health, women’s leadership and diversity, equity, and inclusion (DEI). She is an author of close to 40 peer-reviewed scientific papers. Dr. Garner was also a 2019 awardee of the PharmaVoice 100 Most Inspiring Individuals in the life sciences industry and is the 2022 recipient of the Woman in Science Award from the American Medical Women’s Association.

  • Author:

    Alice Zheng, MD, MBA, MPH

    Principal
    RH Capital

    Alice Zheng, MD, MBA, MPH

    Principal
    RH Capital
  • Author:

    Mimi Ghosh

    Middle Market Financial Sponsors Group
    Bank of America

    Mimi Ghosh

    Middle Market Financial Sponsors Group
    Bank of America
  • Author:

    Allison Watkins

    Founder/CEO
    Watkins-Conti

    Allison Watkins

    Founder/CEO
    Watkins-Conti
  • Author:

    Dora Hughes

    Chief Medical Officer
    The CMS Innovation Center at the Centers for Medicare & Medicaid Services

    Dora Hughes

    Chief Medical Officer
    The CMS Innovation Center at the Centers for Medicare & Medicaid Services
  • Author:

    Tami L Wahl

    Government Affairs, Public Policy
    Modern Advocates

    Tami L Wahl

    Government Affairs, Public Policy
    Modern Advocates
  • Author:

    Sandy Milligan, MD, JD

    Head of Research & Development
    Organon

    Sandy Milligan, MD, JD

    Head of Research & Development
    Organon
  • Author:

    Lucy Perez

    PhD, Senior Principal
    McKinsey & Company

    Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

    Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

    Lucy Perez

    PhD, Senior Principal
    McKinsey & Company

    Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

    Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

  • Author:

    Rachel Robinson

    Chief Operating Officer
    MassMedic

    Rachel Robinson

    Chief Operating Officer
    MassMedic
  • Author:

    Katie Schubert

    Society of Women's Health Research

    Katie Schubert

    Society of Women's Health Research
  • Author:

    Diana Contreras

    Chief Health Strategy Officer
    Planned Parenthood Federation of America

    Diana Contreras

    Chief Health Strategy Officer
    Planned Parenthood Federation of America
  • Author:

    Libby Greer

    Partner
    Forbes Tate Partners

    Libby Greer

    Partner
    Forbes Tate Partners
  • Author:

    Anna Daily

    Founder
    Namida Lab

    Anna Daily

    Founder
    Namida Lab
  • Author:

    Brian Wilson

    New Business Development Partner, Pharma and Medical Businesses
    Celanese

    Brian Wilson

    New Business Development Partner, Pharma and Medical Businesses
    Celanese
  • Author:

    Audrey Sheppard

    President
    Audrey Sheppard Women's Health Consulting

    Audrey Sheppard

    President
    Audrey Sheppard Women's Health Consulting
  • Author:

    Suzanne Steinbaum

    CEO & Founder
    Heart-tech Health

    Suzanne Steinbaum

    CEO & Founder
    Heart-tech Health
  • Author:

    Michael Annichine

    CEO
    Magee-Womens Research Institute

    Michael Annichine

    CEO
    Magee-Womens Research Institute
  • Author:

    Ru-fong Joanne Cheng

    Director, Women’s Health Innovations
    Bill & Melinda Gates Foundation

    Ru-fong Joanne Cheng

    Director, Women’s Health Innovations
    Bill & Melinda Gates Foundation
  • Author:

    Candace Tingen

    Program Officer
    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    Candace Tingen

    Program Officer
    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • Author:

    Bethany Corbin

    Founder & CEO
    FemInnovation

    Bethany Corbin

    Founder & CEO
    FemInnovation
  • Author:

    Linda Goler Blount

    Chief Executive Officer
    Black Women’s Health Imperative

    Linda Goler Blount

    Chief Executive Officer
    Black Women’s Health Imperative
  • Author:

    Liz Powell

    Founder & President
    G2G Consulting

    Liz Powell

    Founder & President
    G2G Consulting
  • Author:

    Primavera Spagnolo, MD, PhD

    Scientific Director, Connors Center for Women’s Health and Gender Biology
    Brigham and Women’s Hospital

    Primavera Spagnolo, MD, PhD

    Scientific Director, Connors Center for Women’s Health and Gender Biology
    Brigham and Women’s Hospital
  • Author:

    Elizabeth Cherot

    MD, MBA, Chief Medical Officer
    March of Dimes

    Elizabeth Cherot

    MD, MBA, Chief Medical Officer
    March of Dimes
  • Author:

    Bethany Young Holt

    Executive Director & Founder
    CAMI Health

    Bethany Young Holt

    Executive Director & Founder
    CAMI Health
  • Author:

    Abigail Sirus

    Investor
    Special Situations Fund

    Abigail Sirus

    Investor
    Special Situations Fund
  • Author:

    Traci Keen

    CEO
    Mate Fertility

    Traci Keen

    CEO
    Mate Fertility
  • Author:

    Rachel Braun Scherl

    Co-Founder & Managing Partner
    SPARK Solutions for Growth

    Rachel Braun Scherl

    Co-Founder & Managing Partner
    SPARK Solutions for Growth
  • Author:

    Kerry Rupp

    General Partner
    True Wealth Ventures

    Kerry Rupp

    General Partner
    True Wealth Ventures
  • Author:

    Golnoush Golshirazi

    CEO & Co-Founder
    ScreenMe

    Golnoush Golshirazi

    CEO & Co-Founder
    ScreenMe
  • Author:

    Oriana Papin-Zoghbi

    CEO & Co-Founder
    AOA Dx

    Oriana Papin-Zoghbi

    CEO & Co-Founder
    AOA Dx
  • Author:

    Lisa Tate

    Director of Partnerships & Strategic Development
    American Medical Women’s Association

    Lisa Tate

    Director of Partnerships & Strategic Development
    American Medical Women’s Association
  • Author:

    Bilikis Oladimeji

    MD, MMCi, CPHIMS Senior Director of Health Informatics
    Optum

    Bilikis Oladimeji

    MD, MMCi, CPHIMS Senior Director of Health Informatics
    Optum
  • Author:

    Nicole St. Jean

    Executive Director, External Business Strategy Head for Precision Medicine, Oncology Experimental Medicine Unit
    GSK

    Nicole St. Jean

    Executive Director, External Business Strategy Head for Precision Medicine, Oncology Experimental Medicine Unit
    GSK
  • Author:

    Crystal Tyler

    PHD, MPH, Chief Health Officer
    Rhia Ventures

    Crystal Tyler

    PHD, MPH, Chief Health Officer
    Rhia Ventures
  • Author:

    Elizabeth Bailey

    Managing Director
    RH Capital

    Elizabeth Bailey

    Managing Director
    RH Capital
  • Author:

    Lisa Rohan

    PhD, Professor of Pharmaceutical Sciences in the department of Pharmacy
    University of Pittsburgh

    Lisa Rohan

    PhD, Professor of Pharmaceutical Sciences in the department of Pharmacy
    University of Pittsburgh
  • Author:

    Nada Hanafi

    SVP - Regulatory Strategy
    Veranex

    Nada Hanafi

    SVP - Regulatory Strategy
    Veranex
  • Author:

    Kathryn Capanna

    Assistant Director of CDRH and Strategic Programs
    FDA

    Kathryn Capanna

    Assistant Director of CDRH and Strategic Programs
    FDA
  • Author:

    Sara Tancman

    Founder & CEO
    Briah Foundation

    Sara Tancman

    Founder & CEO
    Briah Foundation
  • Author:

    Cecile Brosset

    Co-founder & CEO
    Sonio

    Cecile Brosset

    Co-founder & CEO
    Sonio
  • Author:

    Natalie Buford-Young

    CEO
    Springboard Enterprises

    Natalie Buford-Young

    CEO
    Springboard Enterprises
  • Author:

    Jennifer Fried

    Venture Partner / Lead Investor - FemTech
    Portfolia

    Jennifer Fried

    Venture Partner / Lead Investor - FemTech
    Portfolia
  • Author:

    Megann Vaughn Watters

    Head of Labcorp Venture Fund
    Labcorp

    Megann Vaughn Watters

    Head of Labcorp Venture Fund
    Labcorp
  • Author:

    Jenna Jung

    VC Investment Associate
    Joyance Partners

    Jenna Jung

    VC Investment Associate
    Joyance Partners
  • Author:

    Aceil Halaby

    Founder & COO
    Bloomer Tech

    Aceil Halaby

    Founder & COO
    Bloomer Tech
  • Author:

    Sonya Bhavsar

    Director of Product Development
    Abiomed

    Sonya Bhavsar

    Director of Product Development
    Abiomed
  • Author:

    Simmone Taitt

    Founder & CEO

    Simmone Taitt

    Founder & CEO
  • Author:

    Marissa Fayer

    CEO & Founder
    HERhealthEQ

    Marissa Fayer

    CEO & Founder
    HERhealthEQ
  • Author:

    Jill F Schiaparelli

    President & CEO
    Avation Medical

    Jill F Schiaparelli

    President & CEO
    Avation Medical
  • Author:

    Jamie White

    Health Science Strategy and Relations Lead in the Office of Research on Women’s Health
    The National Institute of Health (NIH)

    Jamie White

    Health Science Strategy and Relations Lead in the Office of Research on Women’s Health
    The National Institute of Health (NIH)
  • Author:

    Vrunda Desai

    MD, FACOG, Vice President of Medical Affairs,
    CooperSurgical

    Vrunda Desai

    MD, FACOG, Vice President of Medical Affairs,
    CooperSurgical
  • Author:

    Dr. Neil Parikh

    Chief Medical Officer
    Thirty Madison

    Dr. Neil Parikh is the Chief Medical Officer of Thirty Madison, focused on implementing technology to deliver care at scale. He oversees the clinical, research, and strategic partnership organizations within the company. Prior to Thirty Madison, Neil was President of Oscar Medical Group and Senior Medical Director at Oscar Health leading Care Delivery, where he oversaw Oscar’s clinic and telemedicine operations, complex case management, and clinical concierge services. Neil is also an Assistant Clinical Professor at the University of California Los Angeles, where he has been teaching and practicing since 2014. Neil completed his Internal Medicine residency at Cedars Sinai, his MBA at the Wharton School of the University of Pennsylvania, and his MD at the Keck School of Medicine at the University of Southern California. Neil stays connected to philanthropy through Amply, a giving platform he co-founded, and as a member of the Healthcare Advisory Council to the Ronald McDonald House NY. He splits his time between New York and Los Angeles with his wife and two sons.

    Dr. Neil Parikh

    Chief Medical Officer
    Thirty Madison

    Dr. Neil Parikh is the Chief Medical Officer of Thirty Madison, focused on implementing technology to deliver care at scale. He oversees the clinical, research, and strategic partnership organizations within the company. Prior to Thirty Madison, Neil was President of Oscar Medical Group and Senior Medical Director at Oscar Health leading Care Delivery, where he oversaw Oscar’s clinic and telemedicine operations, complex case management, and clinical concierge services. Neil is also an Assistant Clinical Professor at the University of California Los Angeles, where he has been teaching and practicing since 2014. Neil completed his Internal Medicine residency at Cedars Sinai, his MBA at the Wharton School of the University of Pennsylvania, and his MD at the Keck School of Medicine at the University of Southern California. Neil stays connected to philanthropy through Amply, a giving platform he co-founded, and as a member of the Healthcare Advisory Council to the Ronald McDonald House NY. He splits his time between New York and Los Angeles with his wife and two sons.

  • Author:

    Priyanka Jain

    Co-Founder & CEO
    Evvy

    Priyanka Jain

    Co-Founder & CEO
    Evvy
  • Author:

    Lindsey Taylor Wood

    Founder & General Partner
    The Helm

    Lindsey Taylor Wood

    Founder & General Partner
    The Helm
  • Author:

    Laura Yecies

    CEO & Founder
    Bone Health Technologies

    Laura Yecies is the CEO of Bone Health Technologies, maker of OsteoBoost, the first effective and safe non-drug treatment for low bone density.  Previously she was CEO of SyncThink a medical diagnostic company, Catch, which she sold to Apple and SugarSync which was acquired by J2Global.  Earlier she led the Browser division at Netscape, was general manager of Yahoo Mail and VP of Marketing at Check Point.  Ms. Yecies has led commercialization and product development programs that have resulted in the use by over 350m customers.  She received her MBA from Harvard, has an MSFS from Georgetown and her AB in Government Magna Cum Laude from Dartmouth.   She has been profiled in the NYTimes and multiple periodicals and is a prolific speaker and writer on health care and technology.

    Laura Yecies

    CEO & Founder
    Bone Health Technologies

    Laura Yecies is the CEO of Bone Health Technologies, maker of OsteoBoost, the first effective and safe non-drug treatment for low bone density.  Previously she was CEO of SyncThink a medical diagnostic company, Catch, which she sold to Apple and SugarSync which was acquired by J2Global.  Earlier she led the Browser division at Netscape, was general manager of Yahoo Mail and VP of Marketing at Check Point.  Ms. Yecies has led commercialization and product development programs that have resulted in the use by over 350m customers.  She received her MBA from Harvard, has an MSFS from Georgetown and her AB in Government Magna Cum Laude from Dartmouth.   She has been profiled in the NYTimes and multiple periodicals and is a prolific speaker and writer on health care and technology.

  • Author:

    Karolynn Echols

    MD, FACOG, FPMRS, FABOIM, Director and Associate Professor Female Pelvic Medicine and Reconstructive Surgery
    Thomas Jefferson University

    Karolynn Echols

    MD, FACOG, FPMRS, FABOIM, Director and Associate Professor Female Pelvic Medicine and Reconstructive Surgery
    Thomas Jefferson University
  • Author:

    Kalahn Taylor-Clark

    Faculty in Executive Education
    Business School

    Kalahn Taylor-Clark

    Faculty in Executive Education
    Business School
  • Author:

    Valerie Palmieri

    CEO
    MOMENTUM Consulting

    Valerie Palmieri

    CEO
    MOMENTUM Consulting
  • Author:

    Holly Rockweiler

    CEO & Co-Founder
    Madorra

    Holly Rockweiler

    CEO & Co-Founder
    Madorra
  • Author:

    Melisa Margraves

    Healthcare and Life Sciences Sales Leader
    Hewlett Packard Enterprises

    Melisa Margraves

    Healthcare and Life Sciences Sales Leader
    Hewlett Packard Enterprises
  • Author:

    Lisa Marceau

    Co-Founder
    Joyuus

    Lisa Marceau

    Co-Founder
    Joyuus
  • Author:

    Michelle Darian

    MS, MPH, RD, Marketing Manager of Science and Product
    Inside Tracker

    Michelle Darian

    MS, MPH, RD, Marketing Manager of Science and Product
    Inside Tracker
  • Author:

    Jin Lee

    PhD
    Oxford Angel Fund

    Jin Lee

    PhD
    Oxford Angel Fund
  • Author:

    Michele Van Patten Frank

    Partner
    Venable

    Michele Van Patten Frank

    Partner
    Venable
  • Author:

    Donna Parr

    Managing Partner
    Cross-Border Impact Ventures

    Donna Parr

    Managing Partner
    Cross-Border Impact Ventures
  • Author:

    Michelle Perugini

    CEO & Co-Founder
    Presagen

    Michelle Perugini

    CEO & Co-Founder
    Presagen
  • Author:

    Arianne Kidder

    Partner
    Seae Ventures

    Arianne Kidder

    Partner
    Seae Ventures
  • Author:

    Kristine Ball

    CEO
    Antiva Biosciences

    Kristine Ball

    CEO
    Antiva Biosciences
  • Author:

    Juan Camilo Arjona Ferreira

    Head of Research & Development and Chief Medical Officer
    Organon

    Juan Camilo Arjona Ferreira

    Head of Research & Development and Chief Medical Officer
    Organon
  • Author:

    Delphine O’Rourke

    President & CEO
    WellCity

    Delphine O’Rourke

    President & CEO
    WellCity
  • Author:

    Martin Gershon

    Managing Partner & CIO
    Endeavor Life Sciences Venture Funds

    Dr. Martin Gershon is the Managing Partner and CIO of Endeavor Life Sciences Venture Funds ($1B AUM) and Venture Studio ($570M AUM). He has been featured on CNBC and in numerous conferences and publications as one of the leading healthcare investors, strategists, futurists and entrepreneurs. Over the past 23 years he raised over $1B, personally founded/exited 6 startups, lead Endeavor Funds to 69 investments, and has served as Senior Strategic Healthcare Advisor for Fortune 500 Companies including McKinsey, Goldman Sachs, Bain Capital, Fidelity, TPG, BlackRock, Tiger Global, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Novartis, Rockefeller Foundation, WHO, and the Bill and Melinda Gates Foundation.

    Dr. Gershon has been honored by Standard and Poor’s as a designated top 100 “Healthcare Industry Leader” and has developed Endeavor into a thriving ecosystem of partnerships with BioPharma, Medtech, Digital Health, and Big Tech companies, world class CEO entrepreneurs, start-up accelerators, and prominent Ivy League universities, medical centers, and business schools like Harvard, Columbia, MIT, NYU, McGill and Johns Hopkins.

    Dr. Gershon is committed to helping emerging CEO/Founder Entrepreneurs and serves as a Lead Mentor for Techstars and as a member of the Techstars Start-Up Selection Committee, Executive-in-Residence and Advisor for Matter Health, Mentor for NYU Berkley Center for Entrepreneurship, Selection Committee Advisor for Ben Franklin Technology Partners, Investor for PlugNPlay Tech Center, Advisory Board Member McGill Innovation Fund, and Investor and Advisor for MassChallenge.

    Dr. Gershon is a former Aspen Institute Business of Health Chair and Senior Fellow, Memorial Sloan-Kettering Cancer Center Mayday Fellow, Harvard and Columbia trained neuroscientist, oncologist, immunologist, FDA attorney, Lecturer and Professor at Harvard, MIT, Johns Hopkins, Oxford, Columbia, Chief of Innovation and Investment at McGill, and a contributing author of healthcare entrepreneurship and finance at Fast Company.

    Martin Gershon

    Managing Partner & CIO
    Endeavor Life Sciences Venture Funds

    Dr. Martin Gershon is the Managing Partner and CIO of Endeavor Life Sciences Venture Funds ($1B AUM) and Venture Studio ($570M AUM). He has been featured on CNBC and in numerous conferences and publications as one of the leading healthcare investors, strategists, futurists and entrepreneurs. Over the past 23 years he raised over $1B, personally founded/exited 6 startups, lead Endeavor Funds to 69 investments, and has served as Senior Strategic Healthcare Advisor for Fortune 500 Companies including McKinsey, Goldman Sachs, Bain Capital, Fidelity, TPG, BlackRock, Tiger Global, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Novartis, Rockefeller Foundation, WHO, and the Bill and Melinda Gates Foundation.

    Dr. Gershon has been honored by Standard and Poor’s as a designated top 100 “Healthcare Industry Leader” and has developed Endeavor into a thriving ecosystem of partnerships with BioPharma, Medtech, Digital Health, and Big Tech companies, world class CEO entrepreneurs, start-up accelerators, and prominent Ivy League universities, medical centers, and business schools like Harvard, Columbia, MIT, NYU, McGill and Johns Hopkins.

    Dr. Gershon is committed to helping emerging CEO/Founder Entrepreneurs and serves as a Lead Mentor for Techstars and as a member of the Techstars Start-Up Selection Committee, Executive-in-Residence and Advisor for Matter Health, Mentor for NYU Berkley Center for Entrepreneurship, Selection Committee Advisor for Ben Franklin Technology Partners, Investor for PlugNPlay Tech Center, Advisory Board Member McGill Innovation Fund, and Investor and Advisor for MassChallenge.

    Dr. Gershon is a former Aspen Institute Business of Health Chair and Senior Fellow, Memorial Sloan-Kettering Cancer Center Mayday Fellow, Harvard and Columbia trained neuroscientist, oncologist, immunologist, FDA attorney, Lecturer and Professor at Harvard, MIT, Johns Hopkins, Oxford, Columbia, Chief of Innovation and Investment at McGill, and a contributing author of healthcare entrepreneurship and finance at Fast Company.

  • Author:

    Luba Soskin

    Global Clinical Lead, Women’s Healthcare
    Bayer Pharmaceuticals

    Luba Soskin

    Global Clinical Lead, Women’s Healthcare
    Bayer Pharmaceuticals
  • Author:

    Rachael Beardsley

    Partner
    Fragomen

    Rachael Beardsley

    Partner
    Fragomen
  • Author:

    Jennifer Berliner, MD, MBA

    Director of Physician Well-Being
    UPMC

    Jennifer Berliner, MD, MBA

    Director of Physician Well-Being
    UPMC
  • Author:

    Susan Nicholson

    MD, FIDSA, Healthcare Consultant
    Healthcare Consultant

    Susan Nicholson

    MD, FIDSA, Healthcare Consultant
    Healthcare Consultant
  • Author:

    Claire Labouteiller

    Medical Devices Project Manager
    42 Technology

    Claire Labouteiller

    Medical Devices Project Manager
    42 Technology
  • Author:

    Sarah Knight

    Head of Healthcare Technology
    42 Technology

    Sarah Knight

    Head of Healthcare Technology
    42 Technology
  • Author:

    Sans Thakur

    Chairwoman
    TOWER Capital

    Sans Thakur

    Chairwoman
    TOWER Capital
  • Author:

    Elizabeth Kester

    Head of Nursing Programs
    Pomelo Care

    Elizabeth Kester

    Head of Nursing Programs
    Pomelo Care
  • Author:

    Anna Mason

    Managing Partner
    Ingeborg Investments

    Anna Mason

    Managing Partner
    Ingeborg Investments
  • Author:

    Carli Feinstein

    Managing Director
    Craft and Commerce

    Carli Feinstein

    Managing Director
    Craft and Commerce
  • Author:

    Mark Gannott

    Founder
    Rogue Innovations

    Mark Gannott

    Founder
    Rogue Innovations
  • Author:

    Melinda Thomas

    Associate Medical Director and Director of the Women’s Health Initiative
    BHCHP

    Melinda Thomas

    Associate Medical Director and Director of the Women’s Health Initiative
    BHCHP
  • Author:

    Kaitlyn Hamilton

    Senior Director, Population Health
    Maven Clinic

    Kaitlyn Hamilton

    Senior Director, Population Health
    Maven Clinic
  • Author:

    Andrew Khair

    Director of Business Development
    Ferring Pharmaceuticals U.S

    Andrew Khair

    Director of Business Development
    Ferring Pharmaceuticals U.S
  • Author:

    Jenny Fernandez

    Director of Communications and Leadership
    Endeavor

    Jenny Fernandez is a leadership coach specializing in working with women CEOs in emerging, high-growth companies. She trained at Kellogg School of Management, where she received her MBA. She is currently a professor at Columbia Business and New York University, teaching Next Gen leaders in Leadership and Marketing.

    She is an active member of the investment community and a big supporter of the Next Gen Women in Tech through partnerships with Endeavor Venture Fund & Venture Studio, Techstars and 100 Coaches Agency. She mentors, advises and coaches women CEOs, Founders and leaders in emerging companies and scaling companies. She develops resilient leaders to solve large social problems through the ability to sense early, respond promptly, and pivot effectively to drive accelerated and transformative growth.

    Her leadership skills have been recognized by the Marshall Goldsmith community, and she is one of the top 100 leadership coaches in the United States. Jenny’s professional journey brings together an understanding of the skills needed to run a fast-moving, emerging company with investor acumen, real-world business savvy, and a dedication to helping future leaders grow their companies.

    Jenny Fernandez

    Director of Communications and Leadership
    Endeavor

    Jenny Fernandez is a leadership coach specializing in working with women CEOs in emerging, high-growth companies. She trained at Kellogg School of Management, where she received her MBA. She is currently a professor at Columbia Business and New York University, teaching Next Gen leaders in Leadership and Marketing.

    She is an active member of the investment community and a big supporter of the Next Gen Women in Tech through partnerships with Endeavor Venture Fund & Venture Studio, Techstars and 100 Coaches Agency. She mentors, advises and coaches women CEOs, Founders and leaders in emerging companies and scaling companies. She develops resilient leaders to solve large social problems through the ability to sense early, respond promptly, and pivot effectively to drive accelerated and transformative growth.

    Her leadership skills have been recognized by the Marshall Goldsmith community, and she is one of the top 100 leadership coaches in the United States. Jenny’s professional journey brings together an understanding of the skills needed to run a fast-moving, emerging company with investor acumen, real-world business savvy, and a dedication to helping future leaders grow their companies.

Other events you might be interested in:

Women's Healthy Aging Innovation Summit

Women's Health Innovation Summit, Europe

Reproductive Health Innovation Summit